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catheter removal (13/41, 31.7%) compared to patients with cath-
eter removal within 24 hours (5/39, 12.8%) (p < 0.01). Multivariate
logistic regression analysis revealed that delayed catheter removal,
the presence of intestinal obstruction, and higher white blood cell
counts in the blood and in the PD effluent were independently asso-
ciated with mortality in FP patients.
♦ Conclusion: These results suggest that immediate cath-
eter removal (i.e., within 24 hours after the diagnosis of
FP) is mandatory in PD patients with FP.
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Peritonitis is one of the most frequent and seriouscomplications of peritoneal dialysis (PD) and 1% –
15% of all peritonitis cases are caused by fungal infec-
tions (1–12). Although fungal peritonitis (FP) in PD pa-
tients is relatively uncommon, it is associated with
significantly high morbidity and mortality. Mortality
rates for FP have been reported as high as 60.5%, and
several studies have demonstrated that abdominal pain
and catheter in situ are associated with mortality in these
patients (10–13). However, the majority of previous
studies included only a small number of patients and did
not evaluate the timing of catheter removal. Recently,
peritonitis treatment recommendations from the Inter-
national Society for Peritoneal Dialysis (ISPD) suggested
that catheters should be removed from FP patients im-
mediately after fungi are identified by either microscopy
or culture (14). However, the effect of early catheter re-
moval on mortality has not been fully explored. In this
study, therefore, we not only determine the risk factors
for mortality but also investigate the effect of immedi-
ate catheter removal on mortality in PD patients with FP.
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♦ Background: Fungal peritonitis (FP) is an uncommon
but serious complication of peritoneal dialysis (PD) and is
associated with high morbidity and mortality. Although
previous studies have demonstrated that abdominal pain
and catheter in situ are associated with mortality in FP pa-
tients, the effect of early catheter removal on mortality
remains largely unexplored. In this study, therefore, we
not only determine the risk factors for mortality but also
investigate the effect of immediate catheter removal on
mortality in PD patients with FP.
♦ Patients and Methods: This retrospective study was con-
ducted on 94 episodes of FP in 1926 patients that under-
went PD at Yonsei University Health System from January
1992 to December 2008. Data including demographic char-
acteristics, laboratory and clinical findings, management,
and outcome were collected from medical records.
♦ Results: Among a total of 2361 episodes of peritonitis,
there were 94 episodes of FP in 92 patients, which ac-
counted for 4.0% of all peritonitis episodes and occurred
in 4.8% of patients. Mean age of patients was 52.1 years
and mean duration of PD before contracting FP was 46.1
months. The presenting symptoms included turbid dialy-
sate (93.6%), abdominal pain (84.0%), and fever
(66.0%). Intestinal obstruction was complicated in 39 epi-
sodes (41.5%). 75% of FP was caused by Candida species,
among which Candida albicans was the most common
pathogen, accounting for 41.5% of all episodes of FP. The
PD catheter was removed within 24 hours in 39 patients
(41.5%), whereas catheter removal was performed be-
tween 2 and 9 days after the diagnosis of FP in 42 patients
(44.7%). 27 patients (28.7%) died as a result of FP, 59 pa-
tients (62.8%) required a change to hemodialysis, and PD
was resumed in 8 episodes (8.5%). In addition, the mor-
tality rate was significantly higher in patients with delayed
This single copy is for your personal, non-commercial use only. 
For permission to reprint multiple copies or to order presentation-ready copies 


























PDI JANUARY 2011 – VOL. 31, NO. 1 PREDICTORS OF MORTALITY IN FUNGAL PERITONITIS
trast, death after 4 weeks of diagnosis of FP in a pa-
tient without active peritonitis, even during the hospi-
talization period, was classified as death unrelated
to FP.
STATISTICAL ANALYSIS
All values are expressed as mean ± standard devia-
tion (SD) for parametric data, median values with inter-
quartile range for nonparametric data, or percentages.
Statistical analyses were performed using SPSS version
13.0 (SPSS Inc., Chicago, IL, USA). Data were analyzed
using Student’s t-test, chi-square, or Fisher’s exact test
for comparisons. Independent risk factors for FP-related
mortality were determined by logistic regression analy-
sis including all covariates with a p value less than 0.10
on univariate analysis. Interactions between the signifi-
cant covariates were also examined for all analyses. A
p value less than 0.05 was considered statistically
significant.
RESULTS
DEMOGRAPHIC, CLINICAL, AND LABORATORY DATA
A total of 2267 episodes of bacterial peritonitis and
94 episodes of FP (in 92 patients) were recorded in 1926
patients treated with PD between January 1992 and De-
cember 2008. Fungal peritonitis therefore accounted for
4.0% of all peritonitis episodes and occurred in 4.8% of
the patients. The overall rates of bacterial peritonitis
and FP were 0.38 and 0.02 episodes per patient-year
respectively.
Demographic characteristics, clinical findings, and
laboratory data are shown in Table 1. Mean age of the
patients at the time of FP was 52.1 (range 18 – 77) years,
52.1% were females, and patients were on PD for a mean
of 46.1 (range 0.5 – 194.4) months. Thirty-two episodes
(34.0%) of FP developed during treatment of bacterial
peritonitis and concomitant exit-site infection was ob-
served in 41 episodes (43.6%). Presenting symptoms
included turbid dialysate (93.6%), abdominal pain
(84.0%), and fever (66.0%). Intestinal obstruction was
complicated in 39 episodes (41.5%).
CAUSATIVE ORGANISMS OF FP
The causative organisms of the 94 episodes of FP are
listed in Table 2. Candida species were the most common
pathogens, accounting for 74.5% of all episodes of FP,
among which 55.7% were Candida albicans and 44.3%
were Candida species other than Candida albicans.
PATIENTS AND METHODS
This retrospective study was conducted by reviewing
the medical records of 94 FP cases among 1926 PD pa-
tients that were followed up at Yonsei University Health
System from January 1992 to December 2008. The di-
agnosis of FP was made based on the presence of at least
two of the following criteria: presence of clinical symp-
toms (abdominal pain, fever, cloudy dialysate), pres-
ence of more than 100 leukocytes/mm3 dialysate with
at least 50% polymorphonuclear neutrophils, and docu-
mentation of fungi in dialysate by either smear or cul-
ture (14).
The data recorded included age at the time of FP, gen-
der, duration of PD, cause of end-stage renal disease,
residual renal function, comorbidities, presenting
symptoms and signs, species of fungus causing perito-
nitis, presence of coexisting bacterial peritonitis, an-
tibiotic use within the 3 months prior to FP, history of
treatment with steroids, catheter removal and the time
of removal, and patient outcome. The following labo-
ratory data were obtained at the onset of peritonitis:
peripheral white blood cell (WBC) count, hemoglobin,
blood urea nitrogen, serum creatinine, albumin, and
total cholesterol concentrations, erythrocyte sedimen-
tation rate, C-reactive protein levels, and PD effluent
leukocyte count.
Cardiovascular disease was defined as a history of
coronary, cerebrovascular, or peripheral artery disease.
Coronary disease was defined as history of angioplasty,
coronary artery bypass graft, myocardial infarction, or
angina. Cerebrovascular disease was defined as a pre-
vious transient ischemic attack, stroke, or carotid en-
darterectomy. Peripheral vascular disease was defined
as history of claudication, ischemic limb loss and/or ul-
ceration, or a peripheral revascularization procedure.
Fungal peritonitis complicating bacterial peritonitis
was defined as FP developing during treatment of bac-
terial peritonitis (10). Exit-site infection was defined
by the presence of purulent drainage with or without
erythema of the skin at the catheter–epidermal inter-
face (14). Intestinal obstruction was diagnosed based
on radiographic findings, such as diffusely dilated and
distended air-filled bowel loop, air/fluid levels, or ab-
sence or paucity of colonic gas, in patients with nau-
sea, vomiting, or abdominal distention requiring
antiemetic agents or decompression by a nasogastric
tube. No residual renal function was defined as daily
urine output less than 100 mL at time of presentation.
Death related to FP was defined as death of a patient
with active peritonitis or sepsis secondary to peritoni-
tis or within 4 weeks of diagnosis of FP (14–16). In con-
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TREATMENT
As soon as FP was diagnosed — 15 episodes (16.0%)
by Gram stain and 75 (79.8%) by culture — antifungal
therapy was initiated and was maintained for 2 – 6 weeks.
In 4 episodes (4.3%), antifungal drugs were not given
because the patients died before a diagnosis of FP could
be reached. The regimen used and the route of adminis-
tration were not uniform among patients with FP. Intra-
venous amphoter icin B (0.5 – 1 mg/kg per day,
cumulative dose 0.5 – 2 g) with or without intraperito-
neal amphotericin B was used in 78 episodes (83.0%),
while intravenous or oral fluconazole (200 mg per day)
was used in 12 episodes (12.8%).
Removal of the PD catheter was performed in 88 epi-
sodes (93.6%) after a median duration of 2 (range 1 – 9)
days after the diagnosis of FP; 39 catheters (41.5%) were
removed within 24 hours of the diagnosis of FP (after a
median duration of 2 days after presentation with FP),
whereas 42 catheters (44.7%) were removed at retard
after a median duration of 3 (range 2 – 9) days after the
diagnosis of FP. Before the identification of fungi, 7 cath-
eters (7.4%) were removed due to recurrent peritonitis
or clinical deterioration. The PD catheter was not re-
moved in 6 cases (6.4%); 4 patients (4.3%) died before
the diagnosis of FP and 2 patients (2.1%) refused cath-
eter removal and died after all.
OUTCOME
Table 3 shows the clinical outcomes of patients with
FP. Twenty-seven cases of FP (28.7%) resulted in death,
among which 23 deaths were related to the FP and the
remaining 4 patients died of unrelated causes, includ-
ing acute myocardial infarction, congestive heart fail-
ure, and bacterial pneumonia. The median duration
between the diagnosis of FP and death was 21 (range 3 –
83) days; 16 (range 3 – 28) days for FP-related deaths
and 63 (range 48 – 83) days for FP-unrelated deaths.
Fifty-nine episodes (62.8%) required a change to hemo-
dialysis due to patient preference, intra-abdominal ad-
hesions, or encapsulating peritoneal sclerosis, which
developed in 4 patients (4.3%). PD was resumed in only
8 episodes (8.5%) after a median duration of 42 (range
14 – 112) days after catheter removal.
TABLE 2
Causative Organisms of Ninety-Four Episodes
of Fungal Peritonitis
Causative organism Episodes [n (%)]
Candida species 70 (74.5)
Candida albicans 39 (41.5)
Non-albicans Candida species 31 (33.0)
Candida parapsilosis 12 (12.8)
Candida tropicalis 5 (5.3)
Candida krusei 1 (1.1)
Others 13 (13.8)
Non-Candida species 18 (19.1)
Aspergillus species 7 (7.4)
Penicillium species 3 (3.2)
Trichosporon beigelii 2 (2.1)
Torulopsis glabrata 2 (2.1)
Cryptococcus neoformans 2 (2.1)
Chromomyces species 1 (1.1)
Zygomycetes species 1 (1.1)




Demographic Characteristics, Clinical Findings, and Labora-
tory Data of Ninety-Four Episodes of Fungal Peritonitis (FP)
Age 52.1±12.9 years
Gender (male:female) 45:49
Duration on PD 46.1±39.2 months
Underlying renal disease
Diabetes mellitus 29 (30.9)
Hypertension 23 (24.5)
Chronic glomerulonephritis 21 (22.3)




Diabetes mellitus 38 (40.4)
Cardiovascular disease 40 (42.6)
Prior antibiotic use within 3 months 63 (67.0)
Current use of steroids 6 (6.4)
FP complicating bacterial peritonitis 32 (34.0)
Concomitant exit-site infection 41 (43.6)
No residual renal function at presentation 60 (63.8)
Symptoms and signs
Turbid dialysate 88 (93.6)
Abdominal pain 79 (84.0)
Fever 62 (66.0)
Complication by intestinal obstruction 39 (41.5)
Laboratory findings
Hemoglobin 8.7±1.7 g/dL
Peripheral WBC count 11073±5492/mm3
Serum albumin 2.5±0.6 g/dL
Serum C-reactive protein 12.9±11.2 mg/dL
PD effluent WBC count 1405±1438/mm3
PD = peritoneal dialysis; WBC = white blood cell.
Data are expressed as mean ± standard deviation or number of
episodes (percent).
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The outcome of FP caused by Candida albicans was
significantly worse compared to non-albicans Candida;
14 of 39 episodes of FP (35.9%) caused by Candida
albicans resulted in FP-related mortality, whereas only
4 of 31 episodes of FP (12.9%) caused by non-albicans
Candida resulted in death (p < 0.05).
FACTORS PREDICTING MORTALITY
To determine the independent predictors for FP-
related mortality, 4 patients that died of FP-unrelated
causes and 7 episodes in which the PD catheter was re-
moved before the diagnosis of FP were excluded from the
analysis. Therefore, 83 episodes of FP were analyzed,
among which there were 62 survivors and 21 nonsurvi-
vors. Cardiovascular disease, no residual renal function,
delayed catheter removal (after 24 hours from the diag-
nosis of FP; 31.7% vs 12.8%), Candida albicans infection,
fever at presentation, and complication of intestinal ob-
struction were more prevalent in the nonsurvivor group
than in the survivor group (Table 4). In addition, age and
WBC counts in the blood and PD effluent were signifi-
cantly higher in the nonsurvivor group than in the sur-
vivor group (Table 4).
Multivariate logistic regression analysis was per-
formed with variables that had been revealed as signifi-
cant covariates with a p value less than 0.10 on univariate
analysis. The presence of abdominal pain was also in-
cluded for multivariate analysis because it has been re-
ported as a significant independent risk factor for
FP-related death in many previous studies (10,11). Since
3 patients that died of FP-related causes and with cath-
eter in situ were not eligible for multivariate analysis due
to 100% mortality, only 80 episodes were included in the
analysis. As shown in Table 5, delayed catheter removal,
the presence of intestinal obstruction, and higher WBC
counts in the blood and in the PD effluent were inde-
pendently associated with mortality in patients with FP.
In contrast, age, the presence of cardiovascular disease,
no residual renal function, Candida albicans infection,
and abdominal pain or fever at presentation were not
independent predictors for FP-related mortality. On the
other hand, no significant interactions between these
variables were observed.
DISCUSSION
Fungal peritonitis is a relatively uncommon but seri-
ous complication in PD patients. The results of this study
show that the presence of intestinal obstruction and high
WBC counts in the blood and in the PD effluent are closely
associated with mortality in PD patients with FP. In ad-
dition, we demonstrated that early PD catheter removal
improves survival in these patients, providing concrete
support to the ISPD guidelines of 2005 for early cath-
eter removal for FP.
The incidence of FP in our institute was 4.0% of 2361
peritonitis episodes over a 17-year period, with a FP-
related mortality rate of 24.5%, which is not obviously
different from the results of previous studies (1–13).
Since FP-related mortality is significantly higher than
bacterial peritonitis-related mortality, several investi-
gators have tried to identify the risk factors in predict-
ing mortality in patients with FP. To date, abdominal pain
with or without fever, complication by intestinal obstruc-
tion, and low serum albumin levels have been revealed
as predictors for mortality in FP (10–13). In the present
study, we also found that intestinal obstruction was in-
dependently associated with mortality in FP patients,
which is in accordance with the results of previous stud-
ies. In contrast, this study did not find the presence of
abdominal pain to be a risk factor for mortality. This dis-
parity is likely attributable to the fact that most of our
patients had abdominal pain at presentation.
All previous studies have consistently demonstrated
that PD catheter in situ is an independent factor predict-
ing mortality in FP. Wang et al. (10) reported that overall
mortality rates were significantly higher in their catheter
non-removal group (91%) compared to their removal
group (31%), and catheter remaining in situ was con-
firmed by logistic regression analysis to be a significant
risk factor associated with mortality. In addition, a study
by Prasad et al. (11) showed that there was a significant
difference, as determined by univariate analysis, in mor-
tality between patients with and patients without cath-
eter in situ (100.0% vs 40.9%, p = 0.01). Based on these
two studies, the ISPD  treatment guideline for FP has been
changed from optional PD catheter removal to immedi-
ate removal after the identification of fungi (14,17).
TABLE 3
Clinical Outcomes of Ninety-Four Episodes
of Fungal Peritonitis
Outcome Episodes [n (%)]
Death
Related to peritonitis 23 (24.5)
Sepsis 16 (17.0)
Aspiration pneumonia 3 (3.2)
Upper gastrointestinal bleeding 2 (2.1)
Others 2 (2.1)
Unrelated to peritonitis 4 (4.3)
Changed to hemodialysis 59 (62.8)
Resumed peritoneal dialysis 8 (8.5)
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TABLE 4
Comparisons Between Survivors and Nonsurvivors of Fungal Peritonitis (FP)
Survivors (n=62) Nonsurvivors (n=21) p Value
Age (years) 50.3±12.1 57.1±12.9 <0.05
Gender (male:female) 29:33 10:11 NS
Duration on PD (months) 48.2±37.2 47.8±46.4 NS
Comorbid conditions
Diabetes mellitus 24 (38.7) 10 (47.6) NS
Cardiovascular disease 21 (33.9) 14 (66.7) <0.01
Prior antibiotic use within 3 months 39 (62.9) 16 (76.2) NS
Current use of steroids 2 (3.2) 3 (14.3) NS
FP complicating bacterial peritonitis 23 (37.1) 8 (38.1) NS
Concomitant exit-site infection 29 (46.8) 8 (38.1) NS
No residual renal function at presentation 35 (56.5) 18 (85.7) <0.05
PD catheter <0.01
Removal within 24 hours 34 (54.8) 5 (23.8)
Removal after 24 hours 28 (45.2) 13 (61.9)
In situ 0 (0.0) 3 (14.3)
Causative organism <0.05
Candida albicans 23 (37.1) 14 (66.7)
Non-albicans Candida 25 (40.3) 2 (9.5)
Other species 14 (22.6) 5 (23.8)
Symptoms and signs
Turbid dialysate 53 (85.5) 19 (90.5) NS
Abdominal pain 53 (85.5) 19 (90.5) NS
Fever 35 (56.5) 18 (85.7) <0.05
Complication by intestinal obstruction 20 (32.3) 14 (66.7) <0.01
Laboratory findings
Hemoglobin (g/dL) 8.7±1.8 8.6±1.3 NS
Peripheral WBC count (/mm3) 10 236±4361 13 854±7461 <0.05
Serum albumin (g/dL) 2.5±0.6 2.5±0.5 NS
Serum C-reactive protein (mg/dL) 13.2±10.5 16.7±13.2 NS
PD effluent WBC count (/mm3) 1190±1187 2275±1931 <0.05
PD = peritoneal dialysis; WBC = white blood cell; NS = not significant.
Data are expressed as mean±standard deviation or number of episodes (percent).
TABLE 5
Multivariate Logistic Regression Model for Mortality
Variable OR (95% CI) p Value
Age (per 1 year increase) 1.04 (0.97–1.12) NS
Cardiovascular disease 1.65 (0.28–9.66) NS
No residual renal function at presentation 4.11 (0.51–32.96) NS
Catheter removal after 24 hours 13.73 (2.09–90.36) <0.01
Candida albicans infection 0.31 (0.05–2.04) NS
Abdominal pain 2.33 (0.15–37.35) NS
Fever 6.42 (0.71–57.82) NS
Complication by intestinal obstruction 10.90 (1.41–84.24) <0.05
Peripheral WBC count (per 1000/mm3 increase) 1.23 (1.04–1.46) <0.05
PD effluent WBC count (per 1000/mm3 increase) 2.08 (1.12–3.86) <0.05
WBC = white blood cell; PD = peritoneal dialysis; OR = odds ratio; CI = confidence interval; NS = not significant.
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Even though some investigators have reported suc-
cessful treatment of FP without catheter removal, the
cure rates in most large studies were low (18–20). The
reason for this high treatment failure has been supposed
that fungi colonize and produce a biofilm on the inner
surface of the retained catheter, not only serving as a
nidus for continuous fungal shedding but also render-
ing antifungal therapy less effective (21–23). Therefore,
most clinicians agree that catheter removal is an inte-
gral part of the treatment of FP (5–13). However, con-
crete evidence for the best time for catheter removal in
FP has not been established. Only two studies evaluated
the impact of timing of catheter removal on patient out-
comes in FP. One study demonstrated that mortality was
0% if the catheter was removed within 24 hours, com-
pared to 31% if catheter removal was delayed until after
24 hours (10). Another recent study revealed there was
a significant difference in mortality between FP patients
in whom the catheter was removed within 24 hours of
diagnosis versus after 24 hours (13). Even though there
was a difference in mortality in the former study it did
not reach statistical significance, while the predictive
value of early catheter removal on mortality in the lat-
ter study was not confirmed by multivariate logistic re-
gression analysis, probably due to a relatively small
number of patients. In the present study, we show that
delayed catheter removal more than 24 hours after the
identification of fungi is an independent risk factor pre-
dicting mortality in FP patients. Taken together, it is sug-
gested that immediate catheter removal is mandatory
in PD patients with FP.
Another independent predictor of mortality identified
in this study is high WBC count in the blood and the PD
effluent. A few studies have assessed the value of WBC
counts in PD effluent to predict outcomes in PD patients
with peritonitis but the results are not consistent
(24,25). We suppose that the timing of PD effluent col-
lection may contribute to these conflicting results. In
general, the WBC count in the second dialysate is higher
compared to the initial turbid dialysate in PD peritonitis
patients; it is also known that the WBC count in the PD
effluent depends on the length of the dwell (26,27).
Therefore, even though the results of our study suggest
that the severity of the inflammatory process has an ef-
fect on the outcome of FP, further prospective study with
a clear validation of the initial WBC count in the dialy-
sate is necessary.
The number of FP episodes in the present study is
higher than those of previous studies performed at a
single center in Hong Kong (10) and in the USA (6) that
included 70 and 55 cases respectively. Even though a
very recent study by Miles et al. (9) was conducted on
162 episodes of FP in PD patients, the data were collected
from 66 centers in Australia. Therefore, we consider that
the present study is the largest single-center study on
FP in PD patients. On the other hand, the mortality rate
in our study was 28.7%, which is comparable with that
in the study by Goldie et al. (6), the largest single-cen-
ter study in the USA. When compared to the data from
Hong Kong (10) and the ANZDATA Registry (9), however,
the incidence of death from FP in the present study was
lower relative to the Hong Kong study (44.3%) but
higher relative to the ANZDATA study (9.0%). We sur-
mise that the higher mortality rates in the Hong Kong
study are partly attributable to the longer median du-
ration between the diagnosis of FP and catheter removal
(7 days vs 2 days) and the lower proportion of patients
transferred to permanent hemodialysis (14.5% vs
62.8%). In contrast, the incidence of death in the
ANZDATA study was lower compared to our study, despite
the longer median duration to catheter removal
(5 days). As the authors conceded, the ANZDATA study
did not collect such important information as patient
compliance, individual unit management protocols,
post-infection surveillance programs, and severity of
comorbidities, and lacked an external audit of data ac-
curacy, which may contribute to the difference in the
rates of patient death between the ANZDATA study and
our study.
In conclusion, this study shows that delayed catheter
removal (more than 24 hours after the diagnosis of FP),
complication by intestinal obstruction, and high WBC
counts in the blood and the PD effluent are independent
predictors of mortality in PD patients with FP. These find-
ings suggest that the PD catheter should be removed
immediately and certainly within 24 hours after the iden-
tification of fungi in patients with fungal peritonitis.
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